These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 27072696)
1. Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease. Shrestha L; Bolaender A; Patel HJ; Taldone T Curr Top Med Chem; 2016; 16(25):2753-64. PubMed ID: 27072696 [TBL] [Abstract][Full Text] [Related]
2. Heat shock proteins in cancer: targeting the 'chaperones'. Nahleh Z; Tfayli A; Najm A; El Sayed A; Nahle Z Future Med Chem; 2012 May; 4(7):927-35. PubMed ID: 22571616 [TBL] [Abstract][Full Text] [Related]
3. Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. Chatterjee S; Burns TF Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914774 [TBL] [Abstract][Full Text] [Related]
4. Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention. Narayanankutty V; Narayanankutty A; Nair A Curr Drug Targets; 2019; 20(7):727-737. PubMed ID: 30526455 [TBL] [Abstract][Full Text] [Related]
5. Heat shock protein inhibitors and vaccines as new agents in cancer treatment. Karapanagiotou EM; Syrigos K; Saif MW Expert Opin Investig Drugs; 2009 Feb; 18(2):161-74. PubMed ID: 19236263 [TBL] [Abstract][Full Text] [Related]
6. Heat shock protein antagonists in early stage clinical trials for NSCLC. Hendriks LEL; Dingemans AC Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158 [TBL] [Abstract][Full Text] [Related]
7. The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer. Ischia J; Saad F; Gleave M Curr Opin Urol; 2013 May; 23(3):194-200. PubMed ID: 23385973 [TBL] [Abstract][Full Text] [Related]
8. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239 [TBL] [Abstract][Full Text] [Related]
9. An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy. Olotu F; Adeniji E; Agoni C; Bjij I; Khan S; Elrashedy A; Soliman M Expert Opin Drug Discov; 2018 Oct; 13(10):903-918. PubMed ID: 30207185 [TBL] [Abstract][Full Text] [Related]
10. Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. Taha EA; Ono K; Eguchi T Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533245 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors. Zhang Z; Jing J; Ye Y; Chen Z; Jing Y; Li S; Hong W; Ruan H; Liu Y; Hu Q; Wang J; Li W; Lin C; Diao L; Zhou Y; Han L Genome Med; 2020 Nov; 12(1):101. PubMed ID: 33225964 [TBL] [Abstract][Full Text] [Related]
13. Targeting heat shock protein 90 for anti-cancer drug development. Aswad A; Liu T Adv Cancer Res; 2021; 152():179-204. PubMed ID: 34353437 [TBL] [Abstract][Full Text] [Related]
14. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective. Kumalo HM; Bhakat S; Soliman ME Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815 [TBL] [Abstract][Full Text] [Related]
15. Gong Y; Li T; Yu C; Sun S Front Cell Infect Microbiol; 2017; 7():520. PubMed ID: 29312897 [TBL] [Abstract][Full Text] [Related]
16. Targeting heat shock proteins in prostate cancer. Hessenkemper W; Baniahmad A Curr Med Chem; 2013; 20(22):2731-40. PubMed ID: 23521679 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment. Yang S; Xiao H; Cao L Biomed Pharmacother; 2021 Oct; 142():112074. PubMed ID: 34426258 [TBL] [Abstract][Full Text] [Related]
18. HSP90: a rising star on the horizon of anticancer targets. Dai C; Whitesell L Future Oncol; 2005 Aug; 1(4):529-40. PubMed ID: 16556029 [TBL] [Abstract][Full Text] [Related]